Secondary analysis of a COVID-19 treatment trial: in 643 CMV-seropositive adults needing oxygen, CMV DNAemia occurred in 11% by day 28 and was associated with lower probability of recovery by day 29 (adjusted HR 0.3) and with death.
Secondary analysisn = 643
Boeckh et al. Cytomegalovirus DNAemia in Hospitalized Adults With SARS-CoV-2 Infection Requiring Supplemental Oxygen: Virologic and Clinical Characteristics and Association With Outcomes